Probiotic Allergy Prevention Study

Phase 2

Completed

• Conditions: Allergic disease; Inflammatory and Immune System - Allergies

• Registration Number: ACTRN12606000280505
• Lead Sponsor: Prof Susan Prescott

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2006-07-04
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 180

Inclusion Criteria

Infants at high risk of allergic disease based on maternal allergy.

Exclusion Criteria

Infants were ineligible for the study if their mothers smoked or had pregnancy complications including delivery prior to 37 weeks gestation.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Allergic sensitisation[At 12 months and subsequently at 2 and 5 years];Allergic symptoms[At 12 months and subsequently at 2 and 5 years]

Secondary Outcome Measures

Name	Time	Method
Effects on immune function[At 6 months of age.]